, 2012), no scientific studies thus far have examined the pharmacological Homes of these K2 synthetic cannabinoids or their metabolites at CB2Rs. Consequently, the goal of this review was to determine the affinity and intrinsic action of JWH-018, JWH-073 and a number of other of their main phase I hydroxylated metabolites at human CB2Rs.Generate an